These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 28069625)
1. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial. Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial. Duijzer G; Bukman AJ; Meints-Groenveld A; Haveman-Nies A; Jansen SC; Heinrich J; Hiddink GJ; Feskens EJM; de Wit GA BMC Health Serv Res; 2019 Nov; 19(1):824. PubMed ID: 31711499 [TBL] [Abstract][Full Text] [Related]
3. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. Gillett M; Dallosso HM; Dixon S; Brennan A; Carey ME; Campbell MJ; Heller S; Khunti K; Skinner TC; Davies MJ BMJ; 2010 Aug; 341():c4093. PubMed ID: 20729270 [TBL] [Abstract][Full Text] [Related]
4. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study. Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402 [TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial. Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608 [TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis. Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349 [TBL] [Abstract][Full Text] [Related]
7. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L; Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial). Panca M; Christie D; Cole TJ; Costa S; Gregson J; Holt R; Hudson LD; Kessel AS; Kinra S; Mathiot A; Nazareth I; Wataranan J; Wong ICK; Viner RM; Morris S BMJ Open; 2018 Feb; 8(2):e018640. PubMed ID: 29449292 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D; BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802 [TBL] [Abstract][Full Text] [Related]
10. A multicentred randomised controlled trial of a primary care-based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial. Lamb SE; Lall R; Hansen Z; Castelnuovo E; Withers EJ; Nichols V; Griffiths F; Potter R; Szczepura A; Underwood M; Health Technol Assess; 2010 Aug; 14(41):1-253, iii-iv. PubMed ID: 20807469 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a primary healthcare intervention to treat male lower urinary tract symptoms: the TRIUMPH cluster randomised controlled trial. Cochrane M; Drake MJ; Worthington J; Frost J; Cotterill N; Fader M; McGeagh L; Hashim H; Lane A; Macaulay M; MacNeill S; Rees J; Ridd MJ; Robles LA; Sanderson E; Taylor G; Taylor J; Noble S BMJ Open; 2024 Jan; 14(1):e075704. PubMed ID: 38296301 [TBL] [Abstract][Full Text] [Related]
12. Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial. Gray LJ; Yates T; Troughton J; Khunti K; Davies MJ; PLoS Med; 2016 Jul; 13(7):e1002078. PubMed ID: 27404094 [TBL] [Abstract][Full Text] [Related]
13. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations. Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357 [TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design. Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J Trials; 2015 Nov; 16():496. PubMed ID: 26530718 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial. Dixon P; Hollinghurst S; Edwards L; Thomas C; Gaunt D; Foster A; Large S; Montgomery AA; Salisbury C BMJ Open; 2016 Aug; 6(8):e012352. PubMed ID: 27566642 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M; Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes. Irvine L; Barton GR; Gasper AV; Murray N; Clark A; Scarpello T; Sampson M Int J Technol Assess Health Care; 2011 Oct; 27(4):275-82. PubMed ID: 22004767 [TBL] [Abstract][Full Text] [Related]
18. Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation. Gray LJ; Khunti K; Williams S; Goldby S; Troughton J; Yates T; Gray A; Davies MJ; Cardiovasc Diabetol; 2012 May; 11():56. PubMed ID: 22607160 [TBL] [Abstract][Full Text] [Related]
19. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235 [TBL] [Abstract][Full Text] [Related]